ZURICH, Switzerland, March 17, 2025 – SNAQ, a leading diabetes management platform, has unveiled its latest innovation: an AI-powered meal glucose prediction feature. This new capability provides users of continuous glucose monitors (CGMs) with personalized forecasts of their glucose response to any given meal, even before they eat.
Early user feedback has been highly promising, highlighting the significance of this advancement.
Leveraging a proprietary deep learning model, SNAQ’s meal glucose predictions utilize a digital twin approach, a first in the diabetes sector. This model is built upon a comprehensive dataset that incorporates dietary intake, glucose levels, insulin usage, and physical activity. The result is actionable insights that enable users to optimize their food choices and improve blood sugar management.
“Our meal glucose prediction feature represents a major step forward in diabetes care,” stated Nico Previtali, CTO of SNAQ. “This isn’t just another addition to a CGM app; it’s an unprecedented application of AI and deep learning in personal health. By analyzing extensive real-world data, our technology delivers precise glucose forecasts, providing users with previously unavailable insights.”
In addition to this technological milestone, SNAQ also announced the successful closure of its most recent financing round, led by the Diabetes Venture Fund at Serpentine Ventures. This funding round positions the company well to achieve profitability in a challenging fundraising environment, underscoring investors’ confidence in SNAQ’s vision and technology.
“We remain impressed by the transformative possibilities of the SNAQ platform and its pioneering approach to addressing real and pressing needs,” said Craig Cooper, Partner at Serpentine Ventures. “The technology is backed by strong data, the team continues to execute flawlessly, and this latest breakthrough is further evidence of their considerable progress.”
“This funding validates the impact SNAQ is having in the diabetes space,” said Aurelian Briner, CEO of SNAQ. “We now have the resources to scale our innovations and continue to transform diabetes management for millions worldwide.”
SNAQ plans to introduce additional diabetes innovations in the future, continuing to leverage its proprietary data and advancements in AI. With its commitment to the impact of food on health, SNAQ remains at the forefront of empowering individuals with diabetes to make better-informed decisions regarding their nutrition and health.
For further information, please visit www.snaq.ai or contact [email protected].
About SNAQ
SNAQ is an AI-driven diabetes management platform that delivers personalized glucose insights to help individuals optimize their nutrition. Its image-based carbohydrate counting tool is patented, clinically validated, and trusted by over 200,000 users. By leveraging real-world data and AI, SNAQ empowers both patients and healthcare professionals to make informed mealtime decisions.
